Evolus
EOLS
Evolus (EOLS) news
Recent news
Evolus - under terms, co to lead U.S. regulatory approval and commercialization of Profhilo
AInvest Wire · Jul 8, 2026Evolus - agreement not expected to impact 2026 or 2028 financial targets
AInvest Wire · Jul 8, 2026Evolus - May offer up to $250 mln of securities - SEC filing
Evolus, Inc. (Nasdaq: EOLS) has filed with the U.S. Securities and Exchange Commission (SEC) a registration statement for a potential offering of up to $250 million in securities, according to a recent SEC filing. The company has not disclosed the specific terms of the offering, including the…
AInvest Wire · Jun 5, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.